Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
Condition:   Uveal Melanoma Interventions:   Device: Novocure Optune;   Drug: Opdivo;   Drug: Yervoy Sponsors:   HonorHealth Research Institute;   NovoCure Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2021 Category: Research Source Type: clinical trials